DE3362287D1 - Improvements in or relating to de(mycinosyloxy)tylosin derivatives - Google Patents

Improvements in or relating to de(mycinosyloxy)tylosin derivatives

Info

Publication number
DE3362287D1
DE3362287D1 DE8383303747T DE3362287T DE3362287D1 DE 3362287 D1 DE3362287 D1 DE 3362287D1 DE 8383303747 T DE8383303747 T DE 8383303747T DE 3362287 T DE3362287 T DE 3362287T DE 3362287 D1 DE3362287 D1 DE 3362287D1
Authority
DE
Germany
Prior art keywords
mycinosyloxy
relating
dmot
deoxo
tylosin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE8383303747T
Other languages
German (de)
English (en)
Inventor
Gene Muriel Wild
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Application granted granted Critical
Publication of DE3362287D1 publication Critical patent/DE3362287D1/de
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • C12N1/205Bacterial isolates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/44Preparation of O-glycosides, e.g. glucosides
    • C12P19/60Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin
    • C12P19/62Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin the hetero ring having eight or more ring members and only oxygen as ring hetero atoms, e.g. erythromycin, spiramycin, nystatin
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/465Streptomyces
    • C12R2001/54Streptomyces fradiae
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/8215Microorganisms
    • Y10S435/822Microorganisms using bacteria or actinomycetales
    • Y10S435/886Streptomyces
    • Y10S435/896Streptomyces fradiae

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
DE8383303747T 1982-07-02 1983-06-29 Improvements in or relating to de(mycinosyloxy)tylosin derivatives Expired DE3362287D1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/394,599 US4423148A (en) 1982-07-02 1982-07-02 Process for producing 20-dihydro-20-deoxy-23-de(mycinosyloxy)tylosin

Publications (1)

Publication Number Publication Date
DE3362287D1 true DE3362287D1 (en) 1986-04-03

Family

ID=23559638

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8383303747T Expired DE3362287D1 (en) 1982-07-02 1983-06-29 Improvements in or relating to de(mycinosyloxy)tylosin derivatives

Country Status (11)

Country Link
US (1) US4423148A (ko)
EP (1) EP0098732B1 (ko)
JP (1) JPS5927899A (ko)
KR (1) KR860001997B1 (ko)
AT (1) ATE18233T1 (ko)
CA (1) CA1211731A (ko)
DE (1) DE3362287D1 (ko)
DK (1) DK307083A (ko)
GB (1) GB2122993B (ko)
GR (1) GR78600B (ko)
IL (1) IL69093A (ko)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0343776A3 (en) * 1988-03-28 1991-04-17 Eli Lilly And Company Method for producing 20-deoxotylosin
US5698420A (en) 1995-12-05 1997-12-16 Pfizer Inc. Preparation of 4-deoxy-O-mycaminosyltylonolide
AU2001248588B2 (en) * 2000-04-13 2006-02-02 Biotica Technology Limited Hybrid glycosylated products and their production and use
KR100914251B1 (ko) * 2007-06-27 2009-08-26 이화여자대학교 산학협력단 신규한 올리보실 틸락톤 및 그 제조 방법
CN117510561B (zh) * 2023-11-30 2024-04-02 中国农业科学院饲料研究所 一种泰乐菌素衍生物及其制备方法与应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3178341A (en) * 1960-06-27 1965-04-13 Lilly Co Eli Antibiotics tylosin and desmycosin and derivatives thereof
BE667952A (ko) * 1964-08-05
NL8004922A (nl) 1979-09-19 1981-03-23 Toyo Jozo Kk Deformyltylosinederivaten.
ZA813578B (en) * 1980-06-12 1983-01-26 Lilly Co Eli Macrolide antibiotics
US4366247A (en) * 1980-07-02 1982-12-28 Eli Lilly And Company Process for preparing tylactone
US4299953A (en) * 1980-07-29 1981-11-10 Eli Lilly And Company Mycarosyltylactone
US4304856A (en) * 1980-11-10 1981-12-08 Eli Lilly And Company Process for producing 20-dihydro-20-deoxy-23-demycinosyltylosin

Also Published As

Publication number Publication date
CA1211731A (en) 1986-09-23
US4423148A (en) 1983-12-27
KR840005489A (ko) 1984-11-14
GB2122993A (en) 1984-01-25
DK307083A (da) 1984-01-03
GB8317593D0 (en) 1983-08-03
IL69093A0 (en) 1983-10-31
KR860001997B1 (ko) 1986-11-12
DK307083D0 (da) 1983-07-01
EP0098732B1 (en) 1986-02-26
JPS5927899A (ja) 1984-02-14
GR78600B (ko) 1984-09-27
GB2122993B (en) 1986-01-29
EP0098732A1 (en) 1984-01-18
ATE18233T1 (de) 1986-03-15
IL69093A (en) 1986-09-30

Similar Documents

Publication Publication Date Title
ES8203962A1 (es) Un procedimiento para la preparacion de una macrolida
EP0295248A4 (en) ANTIBIOTIC PREPARATION BASED ON LIPOSOMES.
SE8802985L (sv) Kemiska foereningar och foerfarande foer deras framstaellning
IE782421L (en) Pleuromutilin glycosides
IE850912L (en) 9a-AZA-9a HOMOERYTHROMYCIN DERIVATIVES.
AU504981B1 (en) Bacterial concentrate comprising microccus varians anda lactic acid producing bacteria
MX7303E (es) Procedimiento microbiologico para la preparacion de derivados de antraciclina
IE812616L (en) Macrolide antibiotic
IE832132L (en) C-20-modified macrolide derivatives
GB2122993B (en) Improvements in or relating to de(mycinosyloxy)tylosin derivatives
MY104067A (en) Epipodophyllotoxin glucoside 4''-acyl derivatives
ZA884653B (en) Antitumor agent obtained by microbial stereoselective reduction of 4'-deoxy-4'-iododoxorubicin
PL256535A1 (en) Mremixes and/or fodder additives
EP0316124A3 (en) Ethylated avermectins
ES8506043A1 (es) Un procedimiento para la preparacion de una macrolida.
GR3003852T3 (ko)
IE811707L (en) Macrolide antibiotics
IE790991L (en) Antibiotic produced by cultivating streptomyces species¹nrrl 11298
CA906932A (en) Procede de preparation de la daunorubicine par culture d'un streptomyces

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee